Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease

Peer Review reports

Original Submission
29 Aug 2015	Submitted	Original manuscript
19 Sep 2015	Author responded	Author comments - Felix Popp
Resubmission - Version 2
19 Sep 2015	Submitted	Manuscript version 2
20 Jun 2016	Reviewed	Reviewer Report - Marie Gingras
25 Jul 2016	Reviewed	Reviewer Report - Justin Gundara
27 Jul 2016	Reviewed	Reviewer Report - Andrea Wang-Gillam
13 Dec 2016	Author responded	Author comments - Felix Popp
Resubmission - Version 3
13 Dec 2016	Submitted	Manuscript version 3
16 Dec 2016	Reviewed	Reviewer Report - Marie Gingras
16 Jan 2017	Reviewed	Reviewer Report - Justin Gundara
19 Feb 2017	Author responded	Author comments - Felix Popp
Resubmission - Version 4
19 Feb 2017	Submitted	Manuscript version 4
Publishing
9 Mar 2017	Editorially accepted
29 Mar 2017	Article published	10.1186/s12885-017-3186-8

Back to article page